Skip to main content

and
  1. No Access

    Article

    Use of endocrinological and neurological medication among 5-year survivors of young onset brain tumors

    The burden of late-effects for young onset brain tumor (BT) survivors needs more careful evaluation. Our aim was to assess the need for endocrinological and neurological medication among this specific group. W...

    Mirja Erika Gunn, Tuire Lähdesmäki, Nea Malila, Mikko Arola in Journal of Neuro-Oncology (2016)